Entia Biosciences, Inc. (ERGO)

0,0001 0,0000 (0,00%) Alla chiusura: 11:08AM EDT

Entia Biosciences, Inc.

13565 SW Tualatin-Sherwood Road
Suite 800
Sherwood, OR 97140
United States
971-228-0709
https://www.entiabio.com

Settore/i: Healthcare
Settore: Biotechnology
Impiegati a tempo pieno: 6

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. Marvin S. Hausman M.D.	Chairman and Chief Science & Technology Officer	174k	N/D	1941
Mr. Timothy A. Timmins	CEO & President	141,52k	N/D	1957
Mr. Elliot A. L. Shelton	Secretary and Director	N/D	N/D	1950

Gli importi risalgono al giorno 31 dicembre 2016 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.

Governance aziendale

L'ISS Governance QualityScore di Entia Biosciences, Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.